These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 5075556)

  • 21. Evaluation of serum levels during prolonged combination therapy with phenytoin and phenobarbitone.
    Müller FO; Aucamp AK; Hundt HK; Steyn JM; Olivier LR; Wessels WH
    S Afr Med J; 1977 Aug; 52(9):356-8. PubMed ID: 897947
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improvement in antiepileptic drug levels following reduction of intervals between clinic visits.
    Wannamaker BB; Morton WA; Gross AJ; Saunders S
    Epilepsia; 1980 Apr; 21(2):155-62. PubMed ID: 7358041
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Treatment of epilepsy in the light of the determination of the anticonvulsant blood level].
    Majkowski J
    Neurol Neurochir Pol; 1971; 5(3):295-300. PubMed ID: 5116780
    [No Abstract]   [Full Text] [Related]  

  • 24. The necessity of drug level monitoring in anticonvulsant drug therapy.
    Davis HL; Bailey DG; Johnson GE; Wilson TW
    Can J Physiol Pharmacol; 1976 Dec; 54(6):850-8. PubMed ID: 1021220
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum immunoglobulins in epilepsy.
    Slavin BN; Fenton GM; Laundy M; Reynolds EH
    J Neurol Sci; 1974 Nov; 23(3):353-7. PubMed ID: 4427121
    [No Abstract]   [Full Text] [Related]  

  • 26. Amines, anticonvulsants, and epilepsy.
    Chadwick D; Jenner P; Reynolds EH
    Lancet; 1975 Mar; 1(7905):473-6. PubMed ID: 46954
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic plasma levels of phenytoin, phenobarbital, and carbamazepine: individual variation in relation to seizure frequency and type.
    Schmidt D; Haenel F
    Neurology; 1984 Sep; 34(9):1252-5. PubMed ID: 6540414
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Editorial: Drug levels in epilepsy.
    Lancet; 1975 Aug; 2(7928):264-7. PubMed ID: 49804
    [No Abstract]   [Full Text] [Related]  

  • 29. Development, validation and clinical application of an online-SPE-LC-HRMS/MS for simultaneous quantification of phenobarbital, phenytoin, carbamazepine, and its active metabolite carbamazepine 10,11-epoxide.
    Qu L; Fan Y; Wang W; Ma K; Yin Z
    Talanta; 2016 Sep; 158():77-88. PubMed ID: 27343581
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Quntification of serum levels anticonvulsant].
    Hernández-Peniche J; de Astegui RB
    Prensa Med Mex; 1974; 39(11-12):478-80. PubMed ID: 4457870
    [No Abstract]   [Full Text] [Related]  

  • 31. The effect of long-term antiepileptic treatment on serum cholesterol (TC, HDL, LDL) and triglyceride levels in adult epileptic patients on monotherapy.
    Nikolaos T; Stylianos G; Chryssoula N; Irini P; Christos M; Dimitrios T; Konstantinos P; Antonis T
    Med Sci Monit; 2004 Apr; 10(4):MT50-2. PubMed ID: 15039653
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacology for the pediatrician. Noncompliance contributing to apparent drug failure in status epilepticus.
    Wilson JT
    Pediatrics; 1974 Jun; 53(6):938-40. PubMed ID: 4832435
    [No Abstract]   [Full Text] [Related]  

  • 33. Interaction between plasma phenytoin and phenobarbital concentrations in epileptic patients.
    Nishihara K; Kohda Y; Saitoh Y; Honda Y
    Folia Psychiatr Neurol Jpn; 1979; 33(3):315-7. PubMed ID: 520946
    [No Abstract]   [Full Text] [Related]  

  • 34. [Determination of serum levels of phenobarbital and diphenylhydantoin in the treatment of epilepsy].
    Benetello P; Testa G; Furlanut M
    Clin Ter; 1978 Apr; 85(1):11-8. PubMed ID: 657740
    [No Abstract]   [Full Text] [Related]  

  • 35. [Evaluation of monitoring the efficacy of phenobarbital as an anticonvulsant agents using the fluorescence-polarization immunoassay].
    Karamehić J; Tulumović T; Uzeirbegović M; Trnovcević J; Asćerić M; Hadzibegić N
    Med Arh; 1998; 52(2):65-6. PubMed ID: 9769637
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Micro-determination of serum phenobarbitone and diphenylhydantoin by gas-liquid chromatography.
    Baylis EM; Fry DE; Marks V
    Clin Chim Acta; 1970 Oct; 30(1):93-103. PubMed ID: 5473576
    [No Abstract]   [Full Text] [Related]  

  • 37. [Drug therapy of epilepsy with control of the serum level of anti-epileptic agents].
    Fröscher W
    Fortschr Med; 1979 Jun; 97(23):1073-6. PubMed ID: 456992
    [No Abstract]   [Full Text] [Related]  

  • 38. Measuring anti-convulsant levels in the accident and emergency department.
    McGlone R; Pritty P
    Arch Emerg Med; 1986 Jun; 3(2):141-3. PubMed ID: 3730081
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of methylphenidate on plasma anticonvulsant levels.
    Kupferberg HJ; Jeffery W; Hunninghake DB
    Clin Pharmacol Ther; 1972; 13(2):201-4. PubMed ID: 4552820
    [No Abstract]   [Full Text] [Related]  

  • 40. Monitoring of drug therapy in epileptic children.
    Singh LM; Mehta S; Vohra RM; Nain CK
    Int J Clin Pharmacol Ther Toxicol; 1987 May; 25(5):251-4. PubMed ID: 3596850
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.